Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass

NCT01572545 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: Denosumab
DRUG: Zoledronic acid

Sponsor

Aristotle University Of Thessaloniki

Collaborators

[object Object]
[object Object]